To ensure delivery to your inbox, please add newsletter=40vitacost.com to your address book.
Are you having trouble viewing this email? See it here .

Saturday, January 31, 2009
NSI Longevatrol Stabilized Red Wine Polyphenol Complex w/ Resveratrol -- 200 mg - 60 Licaps
67% off
Retail price:
=2479.99

Our price:
=2425.99


Rating:
NSI GPLC Glycine Propionyl L-Carnitine -- GlycoCarn -1000 mg per serving - 60 Capsules
60% off
Retail price:
=2449.99

Our price:
=2419.99


Rating:
Over 19,000 Health Products
At Your Fingertips=21
Guidelines Unveiled for Treating Clogged Heart Arteries
A key deciding factor should be that benefits outweigh risks, experts say

(HealthDay News) -- Treating patients with symptoms of clogged arteries could become more effective now that leading U.S. cardiology groups have published guidelines for deciding how best to proceed.

Appropriate Use Criteria for Coronary Revascularization, which has been published online and in several leading heart journals, is said to be the first set of guidelines focused on treatment rather than diagnostic testing. The guidelines clarify under what conditions people with chest pain should be treated with just medication and therapy -- or with that combination plus revascularization.

Revascularization is the medical procedure in which proper blood flow to the heart is restored through bypass surgery or use of a balloon-tipped catheter that breaks up plaque in the arteries.

The guidelines categorize people by four main criteria: severity and type of symptoms; plaque levels in the arteries; amount of ischemia (how badly the heart muscle is starved for blood and oxygen, based on stress testing); and whether they already use heart medication.

One of the strengths of this document is that it provides a framework for thinking about clinical scenarios and having a discussion about coronary revascularization, Dr. Manesh R. Patel, chairman of the appropriate use criteria writing group and an assistant professor of medicine at Duke University and the Duke Clinical Research Institute, said in a news release issued by the American College of Cardiology. These recommendations describe when coronary revascularization would be expected to improve a patient's health status.

The guidelines were developed by a 17-member panel of experts from the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, the Society of Thoracic Surgeons, the American Association for Thoracic Surgery, the American Heart Association and the American Society of Nuclear Cardiology. The panel examined 180 clinical scenarios to determine when revascularization or other measures were appropriate.

The guidelines call for revascularization only if the potential for health and quality-of-life improvements outweigh the possible risks. People with plaque buildup in less than three arteries and little heart muscle at risk, who experience symptoms only during strenuous exercise and are not on medication are not considered candidates for revascularization. The exception would be people already on the best available heart medication to combat severe symptoms, according to the guidelines.

In addition to helping medical professionals, the guidelines could also aid health insurers by providing proper criteria so they can develop uniform policies about payment and preauthorization and perform quality reviews of medical care, according to the news release.

More information

The U.S. National Heart, Lung and Blood Institute has more about coronary revascularization procedures .

-- Kevin McKeever

SOURCE: American College of Cardiology, news release, Jan. 5, 2009
Your informative articles were a real help in educating me and helping me to get away from prescription anti-inflammatories with risky side effects. I now have my life back. I'm walking, bike riding and living=21
By Philip B. from Winter Haven, FL See more customer testimonials
This is a story from HealthDay , a service of ScoutNews, LLC. Copyright =A9 2009 ScoutNews LLC . All rights reserved.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent disease.

Share this information with your friends and family... Pass the News=21

You are subscribed as: proclus=40gnu-darwin.org to the Daily Health Tip. This is a daily communication sent to you as part of a service you subscribed to from Vitacost.com. If you no longer wish to receive issues of the Daily Health Tip, please use this link. To be removed from all Vitacost.com e-mails, please visit this page.

The information in this newsletter is for educational use only. Do not attempt to self-diagnose or treat any condition. Please consult your healthcare practitioner if you believe you may have any of the signs or symptoms discussed above before using any of the nutrients discussed.

You should also consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Prices, promotions and product availability in this advertisement are subject to change without notice. Standard shipping method is 3-7 business days.

Copyright =A92009 Vitacost.com, 5400 NW Broken Sound Blvd. Suite 500, Boca Raton, FL 33487, 1-800-381-0759. All rights reserved. Designated trademarks and brands are the property of their respective owners.
=5BBBC1B9166BC558B30240597E1893E844=5D




--======1233428437404======--